In 2000 was created Cambridge Capital Group, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The fund was located in Europe if to be more exact in United Kingdom.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cambridge Capital Group, startups are often financed by Cambridge Angels group, University of Cambridge Enterprise, Octopus Ventures. The meaningful sponsors for the fund in investment in the same round are 3i Group, University of Cambridge Enterprise, Imperial Innovations. In the next rounds fund is usually obtained by Cambridge Angels group, 3i Group, Nesta Ventures.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Advanced Materials. Among the various public portfolio startups of the fund, we may underline Featurespace, Light Blue Optics, Nujira For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager.
The fund was created by Struan McDougall. The overall number of key employees were 3.
Comparing to the other companies, this Cambridge Capital Group performs on 22 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2013. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Spotta | $4M | 15 Dec 2023 | Cambridge, England, United Kingdom | ||
Cytochroma | $1M | 16 Dec 2021 | City of Edinburgh, Scotland, United Kingdom | ||
Qualus | $1M | 01 Jun 2021 | London, England, United Kingdom | ||
Cambridge GaN Devices | $9M | 18 Feb 2021 | Cambridge, Cambridgeshire, United Kingdom | ||
Porotech | $2M | 08 Apr 2020 | Cambridge, England, United Kingdom | ||
SupaPass | $685K | 30 Mar 2020 | Norwich, England, United Kingdom | ||
SupaPass | $548K | 30 Dec 2018 | United Kingdom, England | ||
Lightpoint Medical | $6M | 06 Dec 2018 | United Kingdom, England, United Kingdom | ||
OBRIZUM Group Ltd. | $1M | 28 Jun 2018 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Spotta | $4M | 15 Dec 2023 | Cambridge, England, United Kingdom | ||
Cytochroma | $1M | 16 Dec 2021 | City of Edinburgh, Scotland, United Kingdom | ||
Qualus | $1M | 01 Jun 2021 | London, England, United Kingdom | ||
Cambridge GaN Devices | $9M | 18 Feb 2021 | Cambridge, Cambridgeshire, United Kingdom | ||
Porotech | $2M | 08 Apr 2020 | Cambridge, England, United Kingdom | ||
SupaPass | $685K | 30 Mar 2020 | Norwich, England, United Kingdom | ||
SupaPass | $548K | 30 Dec 2018 | United Kingdom, England | ||
Lightpoint Medical | $6M | 06 Dec 2018 | United Kingdom, England, United Kingdom | ||
OBRIZUM Group Ltd. | $1M | 28 Jun 2018 | United Kingdom, England |